跳转至内容
Merck
CN
所有图片(4)

文件

P4394

Sigma-Aldrich

顺铂

≥99.99% (trace metal analysis), crystalline, anti-neoplastic agent drug

别名:

顺-二氯二氨基铂(II), 顺式-二胺二氯铂, 顺氯氨铂

登录查看公司和协议定价
所有图片(4)

About This Item

线性分子式:
Pt(NH3)2Cl2
CAS号:
15663-27-1
分子量:
300.05
EC 号:
239-733-8
MDL编号:
MFCD00011623
UNSPSC代码:
12352200
PubChem化学物质编号:
24278632
NACRES:
NA.77

product name

顺铂, crystalline

形式

crystalline

质量水平

200

颜色

yellow

mp

270 °C (lit.)

抗生素抗菌谱

neoplastics

作用机制

DNA synthesis | interferes

创始人

Corden

SMILES字符串

N.N.Cl[Pt]Cl

InChI

1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2

InChI key

LXZZYRPGZAFOLE-UHFFFAOYSA-L

正在寻找类似产品? 访问 产品对比指南

应用

顺-二氨基铂(II)二氯化物已用于：
  • 耳蜗外植体细胞的活力测量
  • 抑制卵巢癌细胞系中的细胞增殖和化学敏感性
  • 口服鳞状细胞癌中MTT [3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物]细胞活力检测

生化/生理作用

有效的化学免疫治疗药物; 通过激活巨噬细胞和免疫系统的其他细胞来刺激免疫反应。顺铂处理的巨噬细胞在体外显示出增强的抗原呈递功能。治疗增加了巨噬细胞中NF-κB的含量和易位。顺铂的作用受激酶、磷酸酶和Ca2+/钙调蛋白的调节。与DNA二核苷酸d（pGpG）形成细胞毒性加合物，诱导链内交联。
强效的铂基抗肿瘤剂。与 DNA 二核苷酸 d(pGpG) 形成细胞毒性加合物，诱导链内交联。

特点和优势

该化合物在受体分类和信号转导手册的 半胱天冬酶 页面上有详细描述。如需浏览其他手册页面，请点击此处。
该化合物是细胞凋亡研究的特色产品。点击此处以了解更多的细胞凋亡特色产品。可访问sigma.com/discover-bsm了解更多关于用于其他研究领域生物活性小分子。
该化合物由Corden开发。如需浏览其他药物开发的化合物和批准的药物/候选药物清单，请单击此处。

储存及稳定性

本品室温保存。密封保存于通风良好处。干燥。详见安全数据说明书(Safety Data Sheet)。

象形图

Skull and crossbonesHealth hazard
GHS06,GHS08

警示用语：

Danger

危险分类

Acute Tox. 2 Oral - Carc. 1B - Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

靶器官

Respiratory system

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

  1. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  2. What is the toxicity of Cisplatin, Product P4394?

    This information can be found on the MSDS Section 11.

  3. How can solutions of Cisplatin, Product P4394, be stored? 

    Sterile solutions in 0.9% sodium chloride protected from light are stable for 28 days at room temperature.

  4. What is the best solvent to use for Cisplatin, Product P4394?

    Pharmaceutical injections of cisplatin are in 0.9% sodium chloride at 1 mg/ml.  A 0.1% solution in 0.9% sodium chloride solution has a pH range of 4.5-6.0 immediately after preparation and can be adjusted with HCl.

  5. What is the half-life of Cisplatin, Product P4394, in DMSO?

    At 37 °C, the half-life of cisplatin in DMSO is 60 minutes. In vivo the half-life of cisplatin is approximately 30 minutes.

  6. Why should DMSO not be used as a solvent for cis-Diammineplatinum (II) dichloride?

    The divalent platinum has a high affinity for sulfur donor ligands and this will displace the chloride.  The use of DMSO as a solvent affects the instability of cisplatin and can affect biological activity.  Sundquist, W. I., et al., Inorg. Chem. 26:1524-1528, 1987.

  7. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  8. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  9. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  10. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

Calpain system protein expression and activity in ovarian cancer
Zhang S, et al.
Journal of Cancer Research and Clinical Oncology, 1-17 (2018)
Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance
Alam M, et al.
Head & Neck (2018)
Yi-Long Wu et al.
The Lancet. Oncology, 14(8), 777-786 (2013-06-21)
The results of FASTACT, a randomised, placebo-controlled, phase 2 study, showed that intercalated chemotherapy and erlotinib significantly prolonged progression-free survival (PFS) in patients with advanced non-small-cell lung cancer. We undertook FASTACT-2, a phase 3 study in a similar patient population.
Lin Hou et al.
Life sciences, 232, 116561-116561 (2019-06-28)
The poor prognosis of ovarian cancer is mainly caused by chemotherapy resistance. Studies show that the Bcl-2 inhibitor ABT737 can significantly improve the effect of cisplatin and induce mitochondrial pathway apoptosis. However, the mechanism of ABT737 increases sensitivity to cisplatin
Vicente Fresquet et al.
Blood, 123(26), 4111-4119 (2014-05-03)
Acquired resistance to targeted drugs is emerging as an obstacle to successful cancer treatment. Recently, a BCL2-selective BH3 mimetic termed ABT-199 showed promising therapeutic results in BCL2-dependent tumors. Based on its high affinity for BCL2, we studied potential mechanisms conferring
查看所有相关文献

商品

Bioactive Molecules for Apoptosis

Apoptosis regulation involves multiple pathways and molecules for cellular homeostasis.

Discover Bioactive Small Molecules for Cell Cycle

Cell cycle phases (G1, S, G2, M) regulate cell growth, DNA replication, and division in proliferating cells.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门